Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06440993
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-05-29
Brief Title:
Durvalumab Intraductal Radiofrequency Ablation ID-RFA in Extrahepatic Cholangiocarcinoma
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Extrahepatic Cholangiocarcinoma |
| Unresectable Perihilar or Ductal CCA |
Keywords: